With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Legal 500, 2020
Chambers UK, 2020
Chambers Asia-Pacific, 2020
Chambers Europe, 2019
The UK exits the EU on 31st January 2020. By virtue of the transition period in the Withdrawal Agreement, EU law will continue to apply in and in relation to the UK only until the 31st December 2020.
In their response to the urgency of the COVID-19 crisis, contracting authorities within Europe have experienced many challenges.
The UK exits the EU on 31st January 2020. By virtue of the transitional period in the Withdrawal Agreement, EU law will continue to apply in and in relation to the UK only until the 31st December 2020.
International law firm Bird & Bird advised global safety equipment manufacturer MSA Safety Incorporated (NYSE: MSA) on the acquisition of U.K.-based Bristol Uniforms (“Bristol”) in an all-cash transaction valued at ...
Bird & Bird LLP has advised Pfizer on the global spin-off and merger of its Upjohn business with Mylan N.V. to form the new global pharmaceutical company with the name Viatris Inc.
We are delighted to announce that we received four prestigious awards at the Who’s Who Legal Awards 2020 held virtually in November.
There are no forthcoming events for this area. Please click on the button below to view past events.
Our new BioTalk article is now live! https://t.co/ZsReBDGT3z
'Indirect infringement in Spanish courts: a trend rev… https://t.co/p8LOQot8LD
Partner James Baillieu will be virtually attending the 7th Annual LSX World Congress @LSXLeaders (1st-5th February… https://t.co/zH7DN0e3R2
In the @LexisNexis case analysis, Senior IP Associate, Will Smith, discusses the decision in Neurim Pharmaceutical… https://t.co/Tn91FgTtbJ